Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction

P. Pacher; L. Liaudet; P. Bai; Jon Mabley; P.M. Kaminski; L. Virag; A. Deb; E. Szabo; Z. Ungvari; M.S. Wolin; J.T. Groves; C. Szabo

doi:10.1161/01.CIR.0000048192.52098.DD

Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction

P. Pacher, L. Liaudet, P. Bai, Jon Mabley, P.M. Kaminski, L. Virag, A. Deb, E. Szabo, Z. Ungvari, M.S. Wolin, J.T. Groves, C. Szabo

University of Brighton

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	896-904
Number of pages	9
Journal	Circulation
Volume	107
Issue number	6
DOIs	https://doi.org/10.1161/01.CIR.0000048192.52098.DD
Publication status	Published - Feb 2003

Access to Document

10.1161/01.CIR.0000048192.52098.DDLicence: Unspecified

http://circ.ahajournals.org/content/107/6/896Licence: Unspecified

Cite this

Pacher, P., Liaudet, L., Bai, P., Mabley, J., Kaminski, P. M., Virag, L., Deb, A., Szabo, E., Ungvari, Z., Wolin, M. S., Groves, J. T., & Szabo, C. (2003). Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation, 107(6), 896-904. https://doi.org/10.1161/01.CIR.0000048192.52098.DD

@article{debc4b6f2abf4d388bf40beb1b76ebdf,

title = "Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction",

author = "P. Pacher and L. Liaudet and P. Bai and Jon Mabley and P.M. Kaminski and L. Virag and A. Deb and E. Szabo and Z. Ungvari and M.S. Wolin and J.T. Groves and C. Szabo",

year = "2003",

month = feb,

doi = "10.1161/01.CIR.0000048192.52098.DD",

language = "English",

volume = "107",

pages = "896--904",

journal = "Circulation",

issn = "1524-4539",

number = "6",

}

TY - JOUR

T1 - Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction

AU - Pacher, P.

AU - Liaudet, L.

AU - Bai, P.

AU - Mabley, Jon

AU - Kaminski, P.M.

AU - Virag, L.

AU - Deb, A.

AU - Szabo, E.

AU - Ungvari, Z.

AU - Wolin, M.S.

AU - Groves, J.T.

AU - Szabo, C.

PY - 2003/2

Y1 - 2003/2

U2 - 10.1161/01.CIR.0000048192.52098.DD

DO - 10.1161/01.CIR.0000048192.52098.DD

M3 - Article

SN - 1524-4539

VL - 107

SP - 896

EP - 904

JO - Circulation

JF - Circulation

IS - 6

ER -